▶ 調査レポート

迅速感染症検査のグローバル市場インサイト・予測(~2027年)

• 英文タイトル:Global Rapid Infectious Disease Test Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。迅速感染症検査のグローバル市場インサイト・予測(~2027年) / Global Rapid Infectious Disease Test Market Insights and Forecast to 2027 / QY2112C03724資料のイメージです。• レポートコード:QY2112C03724
• 出版社/出版日:QYResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は迅速感染症検査の世界市場の現状について調査・分析し、2027年までの市場を予測しました。迅速感染症検査の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(インフルエンザ検査、梅毒検査、エイズ検査、その他)、用途別市場規模(職場試験、病院試験、その他試験)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・迅速感染症検査の世界市場概要
・メーカー別の競争状況、市場シェア
・迅速感染症検査の種類別市場規模:インフルエンザ検査、梅毒検査、エイズ検査、その他
・迅速感染症検査の用途別市場規模:職場試験、病院試験、その他試験
・北米の迅速感染症検査市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの迅速感染症検査市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの迅速感染症検査市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の迅速感染症検査市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの迅速感染症検査市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:ELITech Group、FUJIREBIO、Medcaptain Medical Technology Co., Ltd、Nanjing Liming Bio-products Co., Ltd、Tianjin Era Biology Techology Co., Ltd、Beijing Baicare Biotechnology Co., Ltd、BioTeke Corporation(wuxi) Co.,Ltd、Medical Innovation Ventures、Fago Medical、Bio Group Medical System、Association of Medicine and Analytics、NanoEntek、77 Elektronika
・迅速感染症検査のバリューチェーン・販売チャネル分析
・迅速感染症検査の世界市場動向

Market Analysis and Insights: Global Rapid Infectious Disease Test Market
The global Rapid Infectious Disease Test market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Rapid Infectious Disease Test Scope and Segment
Rapid Infectious Disease Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Infectious Disease Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Influenza Test
Syphilis Test
AIDS Test
Other

Segment by Application
Workplace Testing
Hospital Testing
Other Testing

By Company
ELITech Group
FUJIREBIO
Medcaptain Medical Technology Co., Ltd
Nanjing Liming Bio-products Co., Ltd
Tianjin Era Biology Techology Co., Ltd
Beijing Baicare Biotechnology Co., Ltd
BioTeke Corporation(wuxi) Co.,Ltd
Medical Innovation Ventures
Fago Medical
Bio Group Medical System
Association of Medicine and Analytics
NanoEntek
77 Elektronika

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Rapid Infectious Disease Test Product Introduction
1.2 Market by Type
1.2.1 Global Rapid Infectious Disease Test Market Size Growth Rate by Type
1.2.2 Influenza Test
1.2.3 Syphilis Test
1.2.4 AIDS Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Rapid Infectious Disease Test Market Size Growth Rate by Application
1.3.2 Workplace Testing
1.3.3 Hospital Testing
1.3.4 Other Testing
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Rapid Infectious Disease Test Sales Estimates and Forecasts 2016-2027
2.2 Global Rapid Infectious Disease Test Revenue Estimates and Forecasts 2016-2027
2.3 Global Rapid Infectious Disease Test Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Rapid Infectious Disease Test Regions by Sales
2.4.1 Global Top Rapid Infectious Disease Test Regions by Sales (2016-2021)
2.4.2 Global Top Rapid Infectious Disease Test Regions by Sales (2022-2027)
2.5 Global Top Rapid Infectious Disease Test Regions by Revenue
2.5.1 Global Top Rapid Infectious Disease Test Regions by Revenue (2016-2021)
2.5.2 Global Top Rapid Infectious Disease Test Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Rapid Infectious Disease Test Sales by Manufacturers
3.1.1 Global Top Rapid Infectious Disease Test Manufacturers by Sales (2016-2021)
3.1.2 Global Top Rapid Infectious Disease Test Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Rapid Infectious Disease Test Sales in 2020
3.2 Global Rapid Infectious Disease Test Revenue by Manufacturers
3.2.1 Global Top Rapid Infectious Disease Test Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Rapid Infectious Disease Test Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Rapid Infectious Disease Test Revenue in 2020
3.3 Global Rapid Infectious Disease Test Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rapid Infectious Disease Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rapid Infectious Disease Test Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Rapid Infectious Disease Test Sales by Type
4.1.1 Global Rapid Infectious Disease Test Historical Sales by Type (2016-2021)
4.1.2 Global Rapid Infectious Disease Test Forecasted Sales by Type (2022-2027)
4.1.3 Global Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
4.2 Global Rapid Infectious Disease Test Revenue by Type
4.2.1 Global Rapid Infectious Disease Test Historical Revenue by Type (2016-2021)
4.2.2 Global Rapid Infectious Disease Test Forecasted Revenue by Type (2022-2027)
4.2.3 Global Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
4.3 Global Rapid Infectious Disease Test Price by Type
4.3.1 Global Rapid Infectious Disease Test Price by Type (2016-2021)
4.3.2 Global Rapid Infectious Disease Test Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Rapid Infectious Disease Test Sales by Application
5.1.1 Global Rapid Infectious Disease Test Historical Sales by Application (2016-2021)
5.1.2 Global Rapid Infectious Disease Test Forecasted Sales by Application (2022-2027)
5.1.3 Global Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
5.2 Global Rapid Infectious Disease Test Revenue by Application
5.2.1 Global Rapid Infectious Disease Test Historical Revenue by Application (2016-2021)
5.2.2 Global Rapid Infectious Disease Test Forecasted Revenue by Application (2022-2027)
5.2.3 Global Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
5.3 Global Rapid Infectious Disease Test Price by Application
5.3.1 Global Rapid Infectious Disease Test Price by Application (2016-2021)
5.3.2 Global Rapid Infectious Disease Test Price Forecast by Application (2022-2027)

6 North America
6.1 North America Rapid Infectious Disease Test Market Size by Type
6.1.1 North America Rapid Infectious Disease Test Sales by Type (2016-2027)
6.1.2 North America Rapid Infectious Disease Test Revenue by Type (2016-2027)
6.2 North America Rapid Infectious Disease Test Market Size by Application
6.2.1 North America Rapid Infectious Disease Test Sales by Application (2016-2027)
6.2.2 North America Rapid Infectious Disease Test Revenue by Application (2016-2027)
6.3 North America Rapid Infectious Disease Test Market Size by Country
6.3.1 North America Rapid Infectious Disease Test Sales by Country (2016-2027)
6.3.2 North America Rapid Infectious Disease Test Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada

7 Europe
7.1 Europe Rapid Infectious Disease Test Market Size by Type
7.1.1 Europe Rapid Infectious Disease Test Sales by Type (2016-2027)
7.1.2 Europe Rapid Infectious Disease Test Revenue by Type (2016-2027)
7.2 Europe Rapid Infectious Disease Test Market Size by Application
7.2.1 Europe Rapid Infectious Disease Test Sales by Application (2016-2027)
7.2.2 Europe Rapid Infectious Disease Test Revenue by Application (2016-2027)
7.3 Europe Rapid Infectious Disease Test Market Size by Country
7.3.1 Europe Rapid Infectious Disease Test Sales by Country (2016-2027)
7.3.2 Europe Rapid Infectious Disease Test Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Rapid Infectious Disease Test Market Size by Type
8.1.1 Asia Pacific Rapid Infectious Disease Test Sales by Type (2016-2027)
8.1.2 Asia Pacific Rapid Infectious Disease Test Revenue by Type (2016-2027)
8.2 Asia Pacific Rapid Infectious Disease Test Market Size by Application
8.2.1 Asia Pacific Rapid Infectious Disease Test Sales by Application (2016-2027)
8.2.2 Asia Pacific Rapid Infectious Disease Test Revenue by Application (2016-2027)
8.3 Asia Pacific Rapid Infectious Disease Test Market Size by Region
8.3.1 Asia Pacific Rapid Infectious Disease Test Sales by Region (2016-2027)
8.3.2 Asia Pacific Rapid Infectious Disease Test Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines

9 Latin America
9.1 Latin America Rapid Infectious Disease Test Market Size by Type
9.1.1 Latin America Rapid Infectious Disease Test Sales by Type (2016-2027)
9.1.2 Latin America Rapid Infectious Disease Test Revenue by Type (2016-2027)
9.2 Latin America Rapid Infectious Disease Test Market Size by Application
9.2.1 Latin America Rapid Infectious Disease Test Sales by Application (2016-2027)
9.2.2 Latin America Rapid Infectious Disease Test Revenue by Application (2016-2027)
9.3 Latin America Rapid Infectious Disease Test Market Size by Country
9.3.1 Latin America Rapid Infectious Disease Test Sales by Country (2016-2027)
9.3.2 Latin America Rapid Infectious Disease Test Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Rapid Infectious Disease Test Market Size by Type
10.1.1 Middle East and Africa Rapid Infectious Disease Test Sales by Type (2016-2027)
10.1.2 Middle East and Africa Rapid Infectious Disease Test Revenue by Type (2016-2027)
10.2 Middle East and Africa Rapid Infectious Disease Test Market Size by Application
10.2.1 Middle East and Africa Rapid Infectious Disease Test Sales by Application (2016-2027)
10.2.2 Middle East and Africa Rapid Infectious Disease Test Revenue by Application (2016-2027)
10.3 Middle East and Africa Rapid Infectious Disease Test Market Size by Country
10.3.1 Middle East and Africa Rapid Infectious Disease Test Sales by Country (2016-2027)
10.3.2 Middle East and Africa Rapid Infectious Disease Test Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 ELITech Group
11.1.1 ELITech Group Corporation Information
11.1.2 ELITech Group Overview
11.1.3 ELITech Group Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 ELITech Group Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ELITech Group Recent Developments
11.2 FUJIREBIO
11.2.1 FUJIREBIO Corporation Information
11.2.2 FUJIREBIO Overview
11.2.3 FUJIREBIO Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 FUJIREBIO Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 FUJIREBIO Recent Developments
11.3 Medcaptain Medical Technology Co., Ltd
11.3.1 Medcaptain Medical Technology Co., Ltd Corporation Information
11.3.2 Medcaptain Medical Technology Co., Ltd Overview
11.3.3 Medcaptain Medical Technology Co., Ltd Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Medcaptain Medical Technology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Medcaptain Medical Technology Co., Ltd Recent Developments
11.4 Nanjing Liming Bio-products Co., Ltd
11.4.1 Nanjing Liming Bio-products Co., Ltd Corporation Information
11.4.2 Nanjing Liming Bio-products Co., Ltd Overview
11.4.3 Nanjing Liming Bio-products Co., Ltd Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Nanjing Liming Bio-products Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanjing Liming Bio-products Co., Ltd Recent Developments
11.5 Tianjin Era Biology Techology Co., Ltd
11.5.1 Tianjin Era Biology Techology Co., Ltd Corporation Information
11.5.2 Tianjin Era Biology Techology Co., Ltd Overview
11.5.3 Tianjin Era Biology Techology Co., Ltd Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Tianjin Era Biology Techology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tianjin Era Biology Techology Co., Ltd Recent Developments
11.6 Beijing Baicare Biotechnology Co., Ltd
11.6.1 Beijing Baicare Biotechnology Co., Ltd Corporation Information
11.6.2 Beijing Baicare Biotechnology Co., Ltd Overview
11.6.3 Beijing Baicare Biotechnology Co., Ltd Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Beijing Baicare Biotechnology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Beijing Baicare Biotechnology Co., Ltd Recent Developments
11.7 BioTeke Corporation(wuxi) Co.,Ltd
11.7.1 BioTeke Corporation(wuxi) Co.,Ltd Corporation Information
11.7.2 BioTeke Corporation(wuxi) Co.,Ltd Overview
11.7.3 BioTeke Corporation(wuxi) Co.,Ltd Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 BioTeke Corporation(wuxi) Co.,Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 BioTeke Corporation(wuxi) Co.,Ltd Recent Developments
11.8 Medical Innovation Ventures
11.8.1 Medical Innovation Ventures Corporation Information
11.8.2 Medical Innovation Ventures Overview
11.8.3 Medical Innovation Ventures Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Medical Innovation Ventures Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Medical Innovation Ventures Recent Developments
11.9 Fago Medical
11.9.1 Fago Medical Corporation Information
11.9.2 Fago Medical Overview
11.9.3 Fago Medical Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Fago Medical Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Fago Medical Recent Developments
11.10 Bio Group Medical System
11.10.1 Bio Group Medical System Corporation Information
11.10.2 Bio Group Medical System Overview
11.10.3 Bio Group Medical System Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Bio Group Medical System Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bio Group Medical System Recent Developments
11.11 Association of Medicine and Analytics
11.11.1 Association of Medicine and Analytics Corporation Information
11.11.2 Association of Medicine and Analytics Overview
11.11.3 Association of Medicine and Analytics Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Association of Medicine and Analytics Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Association of Medicine and Analytics Recent Developments
11.12 NanoEntek
11.12.1 NanoEntek Corporation Information
11.12.2 NanoEntek Overview
11.12.3 NanoEntek Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 NanoEntek Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 NanoEntek Recent Developments
11.13 77 Elektronika
11.13.1 77 Elektronika Corporation Information
11.13.2 77 Elektronika Overview
11.13.3 77 Elektronika Rapid Infectious Disease Test Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 77 Elektronika Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 77 Elektronika Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Rapid Infectious Disease Test Value Chain Analysis
12.2 Rapid Infectious Disease Test Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rapid Infectious Disease Test Production Mode & Process
12.4 Rapid Infectious Disease Test Sales and Marketing
12.4.1 Rapid Infectious Disease Test Sales Channels
12.4.2 Rapid Infectious Disease Test Distributors
12.5 Rapid Infectious Disease Test Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rapid Infectious Disease Test Industry Trends
13.2 Rapid Infectious Disease Test Market Drivers
13.3 Rapid Infectious Disease Test Market Challenges
13.4 Rapid Infectious Disease Test Market Restraints

14 Key Findings in The Global Rapid Infectious Disease Test Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Rapid Infectious Disease Test Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Influenza Test
Table 3. Major Manufacturers of Syphilis Test
Table 4. Major Manufacturers of AIDS Test
Table 5. Major Manufacturers of Other
Table 6. Global Rapid Infectious Disease Test Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Rapid Infectious Disease Test Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Rapid Infectious Disease Test Sales by Region (2016-2021) & (K Units)
Table 9. Global Rapid Infectious Disease Test Sales Market Share by Region (2016-2021)
Table 10. Global Rapid Infectious Disease Test Sales by Region (2022-2027) & (K Units)
Table 11. Global Rapid Infectious Disease Test Sales Market Share by Region (2022-2027)
Table 12. Global Rapid Infectious Disease Test Revenue by Region (2016-2021) & (US$ Million)
Table 13. Global Rapid Infectious Disease Test Revenue Market Share by Region (2016-2021)
Table 14. Global Rapid Infectious Disease Test Revenue by Region (2022-2027) & (US$ Million)
Table 15. Global Rapid Infectious Disease Test Revenue Market Share by Region (2022-2027)
Table 16. Global Rapid Infectious Disease Test Sales by Manufacturers (2016-2021) & (K Units)
Table 17. Global Rapid Infectious Disease Test Sales Share by Manufacturers (2016-2021)
Table 18. Global Rapid Infectious Disease Test Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 19. Global Rapid Infectious Disease Test Revenue Share by Manufacturers (2016-2021)
Table 20. Rapid Infectious Disease Test Price by Manufacturers 2016-2021 (US$/Unit)
Table 21. Global Rapid Infectious Disease Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rapid Infectious Disease Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rapid Infectious Disease Test as of 2020)
Table 23. Rapid Infectious Disease Test Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Rapid Infectious Disease Test Product Offered
Table 25. Date of Manufacturers Enter into Rapid Infectious Disease Test Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 28. Global Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 29. Global Rapid Infectious Disease Test Sales Share by Type (2016-2021)
Table 30. Global Rapid Infectious Disease Test Sales Share by Type (2022-2027)
Table 31. Global Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 32. Global Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 33. Global Rapid Infectious Disease Test Revenue Share by Type (2016-2021)
Table 34. Global Rapid Infectious Disease Test Revenue Share by Type (2022-2027)
Table 35. Rapid Infectious Disease Test Price by Type (2016-2021) & (US$/Unit)
Table 36. Global Rapid Infectious Disease Test Price Forecast by Type (2022-2027) & (US$/Unit)
Table 37. Global Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 38. Global Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 39. Global Rapid Infectious Disease Test Sales Share by Application (2016-2021)
Table 40. Global Rapid Infectious Disease Test Sales Share by Application (2022-2027)
Table 41. Global Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 42. Global Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 43. Global Rapid Infectious Disease Test Revenue Share by Application (2016-2021)
Table 44. Global Rapid Infectious Disease Test Revenue Share by Application (2022-2027)
Table 45. Rapid Infectious Disease Test Price by Application (2016-2021) & (US$/Unit)
Table 46. Global Rapid Infectious Disease Test Price Forecast by Application (2022-2027) & (US$/Unit)
Table 47. North America Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 48. North America Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 49. North America Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 50. North America Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 51. North America Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 52. North America Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 53. North America Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 54. North America Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 55. North America Rapid Infectious Disease Test Sales by Country (2016-2021) & (K Units)
Table 56. North America Rapid Infectious Disease Test Sales by Country (2022-2027) & (K Units)
Table 57. North America Rapid Infectious Disease Test Revenue by Country (2016-2021) & (US$ Million)
Table 58. North America Rapid Infectious Disease Test Revenue by Country (2022-2027) & (US$ Million)
Table 59. Europe Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 60. Europe Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 61. Europe Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 62. Europe Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 63. Europe Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 64. Europe Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 65. Europe Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 66. Europe Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 67. Europe Rapid Infectious Disease Test Sales by Country (2016-2021) & (K Units)
Table 68. Europe Rapid Infectious Disease Test Sales by Country (2022-2027) & (K Units)
Table 69. Europe Rapid Infectious Disease Test Revenue by Country (2016-2021) & (US$ Million)
Table 70. Europe Rapid Infectious Disease Test Revenue by Country (2022-2027) & (US$ Million)
Table 71. Asia Pacific Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 72. Asia Pacific Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 73. Asia Pacific Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 74. Asia Pacific Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 75. Asia Pacific Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 76. Asia Pacific Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 77. Asia Pacific Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 78. Asia Pacific Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 79. Asia Pacific Rapid Infectious Disease Test Sales by Region (2016-2021) & (K Units)
Table 80. Asia Pacific Rapid Infectious Disease Test Sales by Region (2022-2027) & (K Units)
Table 81. Asia Pacific Rapid Infectious Disease Test Revenue by Region (2016-2021) & (US$ Million)
Table 82. Asia Pacific Rapid Infectious Disease Test Revenue by Region (2022-2027) & (US$ Million)
Table 83. Latin America Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 84. Latin America Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 85. Latin America Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 86. Latin America Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 87. Latin America Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 88. Latin America Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 89. Latin America Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 90. Latin America Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 91. Latin America Rapid Infectious Disease Test Sales by Country (2016-2021) & (K Units)
Table 92. Latin America Rapid Infectious Disease Test Sales by Country (2022-2027) & (K Units)
Table 93. Latin America Rapid Infectious Disease Test Revenue by Country (2016-2021) & (US$ Million)
Table 94. Latin America Rapid Infectious Disease Test Revenue by Country (2022-2027) & (US$ Million)
Table 95. Middle East and Africa Rapid Infectious Disease Test Sales by Type (2016-2021) & (K Units)
Table 96. Middle East and Africa Rapid Infectious Disease Test Sales by Type (2022-2027) & (K Units)
Table 97. Middle East and Africa Rapid Infectious Disease Test Revenue by Type (2016-2021) & (US$ Million)
Table 98. Middle East and Africa Rapid Infectious Disease Test Revenue by Type (2022-2027) & (US$ Million)
Table 99. Middle East and Africa Rapid Infectious Disease Test Sales by Application (2016-2021) & (K Units)
Table 100. Middle East and Africa Rapid Infectious Disease Test Sales by Application (2022-2027) & (K Units)
Table 101. Middle East and Africa Rapid Infectious Disease Test Revenue by Application (2016-2021) & (US$ Million)
Table 102. Middle East and Africa Rapid Infectious Disease Test Revenue by Application (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Rapid Infectious Disease Test Sales by Country (2016-2021) & (K Units)
Table 104. Middle East and Africa Rapid Infectious Disease Test Sales by Country (2022-2027) & (K Units)
Table 105. Middle East and Africa Rapid Infectious Disease Test Revenue by Country (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Rapid Infectious Disease Test Revenue by Country (2022-2027) & (US$ Million)
Table 107. ELITech Group Corporation Information
Table 108. ELITech Group Description and Major Businesses
Table 109. ELITech Group Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. ELITech Group Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. ELITech Group Recent Developments
Table 112. FUJIREBIO Corporation Information
Table 113. FUJIREBIO Description and Major Businesses
Table 114. FUJIREBIO Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. FUJIREBIO Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. FUJIREBIO Recent Developments
Table 117. Medcaptain Medical Technology Co., Ltd Corporation Information
Table 118. Medcaptain Medical Technology Co., Ltd Description and Major Businesses
Table 119. Medcaptain Medical Technology Co., Ltd Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Medcaptain Medical Technology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Medcaptain Medical Technology Co., Ltd Recent Developments
Table 122. Nanjing Liming Bio-products Co., Ltd Corporation Information
Table 123. Nanjing Liming Bio-products Co., Ltd Description and Major Businesses
Table 124. Nanjing Liming Bio-products Co., Ltd Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Nanjing Liming Bio-products Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Nanjing Liming Bio-products Co., Ltd Recent Developments
Table 127. Tianjin Era Biology Techology Co., Ltd Corporation Information
Table 128. Tianjin Era Biology Techology Co., Ltd Description and Major Businesses
Table 129. Tianjin Era Biology Techology Co., Ltd Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Tianjin Era Biology Techology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Tianjin Era Biology Techology Co., Ltd Recent Developments
Table 132. Beijing Baicare Biotechnology Co., Ltd Corporation Information
Table 133. Beijing Baicare Biotechnology Co., Ltd Description and Major Businesses
Table 134. Beijing Baicare Biotechnology Co., Ltd Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Beijing Baicare Biotechnology Co., Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Beijing Baicare Biotechnology Co., Ltd Recent Developments
Table 137. BioTeke Corporation(wuxi) Co.,Ltd Corporation Information
Table 138. BioTeke Corporation(wuxi) Co.,Ltd Description and Major Businesses
Table 139. BioTeke Corporation(wuxi) Co.,Ltd Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. BioTeke Corporation(wuxi) Co.,Ltd Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. BioTeke Corporation(wuxi) Co.,Ltd Recent Developments
Table 142. Medical Innovation Ventures Corporation Information
Table 143. Medical Innovation Ventures Description and Major Businesses
Table 144. Medical Innovation Ventures Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Medical Innovation Ventures Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Medical Innovation Ventures Recent Developments
Table 147. Fago Medical Corporation Information
Table 148. Fago Medical Description and Major Businesses
Table 149. Fago Medical Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Fago Medical Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Fago Medical Recent Developments
Table 152. Bio Group Medical System Corporation Information
Table 153. Bio Group Medical System Description and Major Businesses
Table 154. Bio Group Medical System Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. Bio Group Medical System Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Bio Group Medical System Recent Developments
Table 157. Association of Medicine and Analytics Corporation Information
Table 158. Association of Medicine and Analytics Description and Major Businesses
Table 159. Association of Medicine and Analytics Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Association of Medicine and Analytics Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Association of Medicine and Analytics Recent Developments
Table 162. NanoEntek Corporation Information
Table 163. NanoEntek Description and Major Businesses
Table 164. NanoEntek Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. NanoEntek Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. NanoEntek Recent Developments
Table 167. 77 Elektronika Corporation Information
Table 168. 77 Elektronika Description and Major Businesses
Table 169. 77 Elektronika Rapid Infectious Disease Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. 77 Elektronika Rapid Infectious Disease Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. 77 Elektronika Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Rapid Infectious Disease Test Distributors List
Table 175. Rapid Infectious Disease Test Customers List
Table 176. Rapid Infectious Disease Test Market Trends
Table 177. Rapid Infectious Disease Test Market Drivers
Table 178. Rapid Infectious Disease Test Market Challenges
Table 179. Rapid Infectious Disease Test Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Rapid Infectious Disease Test Product Picture
Figure 2. Global Rapid Infectious Disease Test Market Share by Type in 2020 & 2027
Figure 3. Influenza Test Product Picture
Figure 4. Syphilis Test Product Picture
Figure 5. AIDS Test Product Picture
Figure 6. Other Product Picture
Figure 7. Global Rapid Infectious Disease Test Market Share by Application in 2020 & 2027
Figure 8. Workplace Testing
Figure 9. Hospital Testing
Figure 10. Other Testing
Figure 11. Rapid Infectious Disease Test Report Years Considered
Figure 12. Global Rapid Infectious Disease Test Sales 2016-2027 (K Units)
Figure 13. Global Rapid Infectious Disease Test Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Rapid Infectious Disease Test Revenue 2016-2027 (US$ Million)
Figure 15. Global Rapid Infectious Disease Test Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 16. Global Rapid Infectious Disease Test Sales Market Share by Region (2016-2021)
Figure 17. Global Rapid Infectious Disease Test Sales Market Share by Region (2022-2027)
Figure 18. North America Rapid Infectious Disease Test Sales YoY (2016-2027) & (K Units)
Figure 19. North America Rapid Infectious Disease Test Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Europe Rapid Infectious Disease Test Sales YoY (2016-2027) & (K Units)
Figure 21. Europe Rapid Infectious Disease Test Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Asia-Pacific Rapid Infectious Disease Test Sales YoY (2016-2027) & (K Units)
Figure 23. Asia-Pacific Rapid Infectious Disease Test Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Latin America Rapid Infectious Disease Test Sales YoY (2016-2027) & (K Units)
Figure 25. Latin America Rapid Infectious Disease Test Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Middle East & Africa Rapid Infectious Disease Test Sales YoY (2016-2027) & (K Units)
Figure 27. Middle East & Africa Rapid Infectious Disease Test Revenue YoY (2016-2027) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Rapid Infectious Disease Test Sales in 2020
Figure 29. The Top 10 and Top 5 Players Market Share by Rapid Infectious Disease Test Revenue in 2020
Figure 30. Rapid Infectious Disease Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 31. Global Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 32. Global Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 33. Global Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 34. Global Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 35. North America Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 36. North America Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 37. North America Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 38. North America Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 39. North America Rapid Infectious Disease Test Sales Share by Country (2016-2027)
Figure 40. North America Rapid Infectious Disease Test Revenue Share by Country (2016-2027)
Figure 41. U.S. Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 42. Canada Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 43. Europe Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 44. Europe Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 45. Europe Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 46. Europe Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 47. Europe Rapid Infectious Disease Test Sales Share by Country (2016-2027)
Figure 48. Europe Rapid Infectious Disease Test Revenue Share by Country (2016-2027)
Figure 49. Germany Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 50. France Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 51. U.K. Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 52. Italy Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 53. Russia Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 54. Asia Pacific Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 55. Asia Pacific Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 56. Asia Pacific Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 57. Asia Pacific Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 58. Asia Pacific Rapid Infectious Disease Test Sales Share by Region (2016-2027)
Figure 59. Asia Pacific Rapid Infectious Disease Test Revenue Share by Region (2016-2027)
Figure 60. China Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 61. Japan Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 62. South Korea Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 63. India Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 64. Australia Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 65. Taiwan Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 66. Indonesia Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 67. Thailand Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 68. Malaysia Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 69. Philippines Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 70. Latin America Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 71. Latin America Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 72. Latin America Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 73. Latin America Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 74. Latin America Rapid Infectious Disease Test Sales Share by Country (2016-2027)
Figure 75. Latin America Rapid Infectious Disease Test Revenue Share by Country (2016-2027)
Figure 76. Mexico Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 77. Brazil Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 78. Argentina Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 79. Middle East and Africa Rapid Infectious Disease Test Sales Market Share by Type (2016-2027)
Figure 80. Middle East and Africa Rapid Infectious Disease Test Revenue Market Share by Type (2016-2027)
Figure 81. Middle East and Africa Rapid Infectious Disease Test Sales Market Share by Application (2016-2027)
Figure 82. Middle East and Africa Rapid Infectious Disease Test Revenue Market Share by Application (2016-2027)
Figure 83. Middle East and Africa Rapid Infectious Disease Test Sales Share by Country (2016-2027)
Figure 84. Middle East and Africa Rapid Infectious Disease Test Revenue Share by Country (2016-2027)
Figure 85. Turkey Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 86. Saudi Arabia Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 87. UAE Rapid Infectious Disease Test Revenue (2016-2027) & (US$ Million)
Figure 88. Rapid Infectious Disease Test Value Chain
Figure 89. Rapid Infectious Disease Test Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed